FDA Issues Emergency Use Authorization For Pfizer Covid-19 Vaccine

The Food and Drug Administration(FDA) has issued an emergency use authorization for the COVID-19 vaccine developed by Pfizer and BioNTech.

This means that some senior officials formed an independent panel to discuss the authorization of the vaccine for emergency use. Likewise, millions of doses of Pfizer will be soon shipped around the country so vaccinations can begin within days.

FDA has issued a statement claiming that available data provide clear evidence that Pfizer-BioNTech COVID-19 Vaccine may be effective in preventing COVID-19.

The data also support that the known and potential benefits outweigh the known and potential risks, supporting the vaccine’s use in millions of people 16 years of age and older.

The United Kingdom has already approved the Pfizer-BioNTech for emergency use and with the United States, it has become the fourth country to approve the Pfizer vaccine.

The shots are known to come with some side effects, including fever, fatigue, headache and muscle and joint pain. Two people in the U.K. were reported to have had severe allergic reactions after getting the shot.